The first telithromycin-resistant Streptococcus pneumoniae isolate in Japan associated with erm(B) and mutations in 23S rRNA and riboprotein L4.
暂无分享,去创建一个
Y. Hirakata | K. Yanagihara | S. Kohno | Y. Miyazaki | K. Izumikawa | K. Tomono | Y. Mizuta | M. Seki | A. Wada | S. Kurihara | A. Kondoh
[1] P. Huovinen,et al. Streptococcus pneumoniae Isolates Resistant to Telithromycin , 2006, Antimicrobial Agents and Chemotherapy.
[2] D. Hoban,et al. Mechanisms of resistance to telithromycin in Streptococcus pneumoniae. , 2005, The Journal of antimicrobial chemotherapy.
[3] D. Farrell,et al. Activities of Telithromycin against 13,874 Streptococcus pneumoniae Isolates Collected between 1999 and 2003 , 2004, Antimicrobial Agents and Chemotherapy.
[4] S. Amyes,et al. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae. , 2003, The Journal of antimicrobial chemotherapy.
[5] R. Lütticken,et al. Ribosomal Mutations Conferring Resistance to Macrolides in Streptococcus pneumoniae Clinical Strains Isolated in Germany , 2003, Antimicrobial Agents and Chemotherapy.
[6] Y. Hirakata,et al. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. , 2002, The Journal of antimicrobial chemotherapy.
[7] R. Leclercq,et al. Diversity of Ribosomal Mutations Conferring Resistance to Macrolides, Clindamycin, Streptogramin, and Telithromycin in Streptococcus pneumoniae , 2002, Antimicrobial Agents and Chemotherapy.
[8] M. Jacobs,et al. Mutations in 23S rRNA and Ribosomal Protein L4 Account for Resistance in Pneumococcal Strains Selected In Vitro by Macrolide Passage , 2000, Antimicrobial Agents and Chemotherapy.
[9] P. Appelbaum,et al. In Vitro Development of Resistance to Telithromycin (HMR 3647), Four Macrolides, Clindamycin, and Pristinamycin inStreptococcus pneumoniae , 2000, Antimicrobial Agents and Chemotherapy.
[10] S. Kudoh,et al. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. , 1998, American journal of respiratory and critical care medicine.
[11] P. Wayne. PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING, NINTH INFORMATIONAL SUPPLEMENT , 2008 .
[12] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .